A specialist in life sciences and technology, Bristows LLP is well-equipped to deliver ‘pragmatic, risk-based advice’ to global pharma, biotech and medical device companies on regulatory matters and licensing, collaboration, and M&A transactions. Its dedicated IP litigation team is recognised for leveraging scientific knowledge to ’tactical advantage’ in precedent-setting cases before UK and European courts. The ‘dedicated’ team is led by experienced patent litigator Liz Cohen and Richard Dickinson, who focuses on commercial transactions and IP advisory. Brian Cordery and Robert Burrows are renowned for their patent litigation experience, while Adrian Chew handles patent enforcement and validity matters. Alex Denoon is ’extremely knowledgeable’ in regulatory matters, especially concerning disruptive technologies, while Xisca Borrás specialises in EU and UK life sciences law. The ‘outstanding’ Claire Smith advises on a range of life sciences transactions alongside Matthew Warren. Competition expert Robert Vidal arrived from Pinsent Masons LLP in January 2025. Gemma Barrett is no longer at the firm.
L'éditorial du Legal 500
Avocats
Leading partners
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Next Generation Partners
Jeunes associés disposant d'une reconnaissance montante sur le marché, jouant régulièrement un rôle clé dans des dossiers majeurs.
Responsable de la pratique
Liz Cohen; Richard Dickinson
Autres avocats clés
Brian Cordery; Robert Burrows; Alex Denoon; Xisca Borrás; Adrian Chew; Claire Smith; Matthew Warren; Robert Vidal